(CIDRAP News) An influenza virusespecially one genetically manipulated for increased virulencewould be an attractive weapon for bioterrorists, according to physicians writing in the Journal of the Royal Society of Medicine.
(CIDRAP News) – The World Health Organization (WHO) has called a Nov 11 "summit" meeting of health officials and vaccine companies to discuss how to confront what is seen as the growing risk that avian influenza will trigger a human flu pandemic.
(CIDRAP News) – US officials this week promoted international efforts to prepare for a potential influenza pandemic, announcing an international flu surveillance partnership and promising aid to Vietnam for avian and human flu surveillance.
Jan 6, 2006 (CIDRAP News) 2005 is likely to go down as the year when avian influenza, powered by a steady rise in human cases and the spread of poultry outbreaks all the way to Eastern Europe, emerged as a high-profile global health issue.
When 2005 dawned, only 45 human cases of H5N1 avian flu, including 32 deaths, had been counted by the World Health Organization (WHO). All of those were in Vietnam and Thailand.
(CIDRAP News) US health officials announced today they have ordered more than 14 million treatment courses of two antiviral drugs to add to the 5.5 million courses already bought in preparation for a possible influenza pandemic.
(CIDRAP News) Drug manufacturer Roche said today it is increasing its production capacity for the antiviral drug oseltamivir (Tamiflu) by a third this year and is keeping ahead of the demand from governments stockpiling the drug in preparation for a possible influenza pandemic.
Editor's note: This is the last in a seven-part series investigating the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. The series puts promising advances in vaccine technology in perspective by illuminating the formidable barriers to producing large amounts of an effective and widely usable vaccine in a short time.
(CIDRAP News) This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.